Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fractals also in pharmacokinetics?

H P Koch1, H Zacek

  • 1Institute of Pharmaceutical Chemistry, University of Vienna, Austria.

Die Pharmazie
|December 1, 1991
PubMed
Summary

Drug and metabolite concentrations in the body can exhibit fractal patterns, showing similar structures at different scales. This fractal concept offers a new way to analyze complex pharmacokinetic time-concentration curves using fractal dimension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A reflection absorption infrared spectroscopy and density-functional theory investigation of methanol dehydrogenation on Rh(111)V alloy surfaces.

The Journal of chemical physics·2005
Same author

[Jaroslav Hladik--a Czech pharmaceutical historian on his jubilee].

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti·2003
Same author

[Drug forms as the subject of a dissertation in the historical past of Charles University].

Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti·2000
Same author

Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters.

Molecular pharmacology·1999
Same author

[Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].

Zeitschrift fur Kardiologie·1999
Same author

[Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].

Zeitschrift fur Kardiologie·1999

Area of Science:

  • Pharmacokinetics
  • Complex Systems Analysis
  • Biomedical Science

Background:

  • Drug and metabolite concentrations in biological systems can exhibit complex temporal behaviors.
  • Traditional pharmacokinetic models may not fully capture the intricate patterns observed in some time-concentration profiles.
  • Fractal geometry offers a framework for describing complex, self-similar structures.

Purpose of the Study:

  • To introduce the concept of fractal patterns in drug and metabolite time-course data.
  • To demonstrate the utility of fractal analysis in pharmacokinetics.
  • To propose a method for quantifying the complexity of time-concentration curves using fractal dimension.

Main Methods:

  • Analysis of drug and metabolite time-concentration data exhibiting irregular patterns.
  • Application of fractal geometry principles to describe these patterns.
  • Introduction of a parameter, 'fractal dimension', to characterize curve complexity.
  • Proposal of a principle to test for 'self-similarity' as evidence for fractal behavior.

Main Results:

  • Observed fractal patterns in the time course of drugs and/or metabolites in body fluids and tissues.
  • Demonstrated that fractal patterns exhibit self-similar structures.
  • Proposed fractal dimension as a valuable parameter for describing complex time-concentration curves in pharmacokinetics.

Conclusions:

  • The fractal concept provides a novel approach to understanding drug and metabolite disposition.
  • Fractal analysis, using fractal dimension, can offer deeper insights into pharmacokinetic complexities.
  • The proposed method for testing self-similarity supports the application of fractal geometry in pharmacokinetics.

Related Experiment Videos